PTH (Parathyroid Hormone)
PTH (Parathyroid Hormone) is a number a lab report prints. What it measures, in the Library's words: These three regulate calcium homeostasis together (see `Function-Health-Hyman.md` for the full physiology) and matter specifically here because postmenopausal bone loss increases the stakes of getting calcium/vitamin D status right ... No single unit is recorded for it on its own; the range note on this page prints the units its entry uses. It is read on the Perimenopause & Menopause panel.
What it measures
These three regulate calcium homeostasis together (see `Function-Health-Hyman.md` for the full physiology) and matter specifically here because postmenopausal bone loss increases the stakes of getting calcium/vitamin D status right; PTH rises when either vitamin D or calcium is insufficient, pulling calcium from bone to keep blood levels normal at bone's expense.
Also printed on lab reports as: pth; pth intact; intact pth; parathyroid hormone; parathyroid hormone intact.
Filed under: Hormones & Fertility.
Range and unit
No single unit is recorded for this marker on its own. The range note below prints the units its entry uses, and your report's own unit comes first.
How the entry records the range: See `Function-Health-Hyman.md` for the full conventional ranges (vitamin D: deficient <20 ng/mL, sufficient ≥30 ng/mL per Endocrine Society; calcium 8.5-10.5 mg/dL). No separate menopause-specific reference range exists for any of the three, though guidance on *intake targets* does shift at menopause (see Bone Nutrients section below).
A range is a reference with a history, never a verdict. Measurement science, not a diagnosis. Your clinician has the last word.
Where it is read
The Library reads PTH (Parathyroid Hormone) on this panel.
Open PTH (Parathyroid Hormone) in the Library, with the studies underneath
Also read on the Perimenopause & Menopause panel
What moves it
A lab number moves with its cofactors, not on its own. These are shown as a set, in alphabetical order; a count is how much has been read, never how strong. Each study id opens the paper the Library records.
Needed to use it, or raises it
Read alongside it
- Iron · named together in 67 studiesHH-45806HH-89819HH-112838
- Phosphorus · named together in 611 studiesHH-0069HH-2799HH-12265
- Potassium · named together in 80 studiesHH-3049HH-22441HH-26790
- Sodium · named together in 108 studiesHH-3049HH-3795HH-135980
- Zinc · named together in 96 studiesHH-12148HH-19236HH-19237
Competes with it, draws it down, or moves it down
Tests a routine panel leaves out
For some of these nutrients the map names a test that a routine blood count, metabolic panel, lipid panel and TSH do not carry: Ferritin and iron studies, Magnesium (red-cell), Vitamin D (25-hydroxy) and Zinc. How to get measured lists where each can be ordered.
The 34 studies behind these rows
- HH-0069Effects of boron supplementation on bone mineral density and dietary blood and urinary calcium phosphorus magnesium and boron in female athletes (1994)
- HH-104580[Vitamin K2] (2008)
- HH-104600The Dual Role of Vitamin K2 in “Bone-Vascular Crosstalk”: Opposite Effects on Bone Loss and Vascular Calcification (2021)
- HH-112838Diet and growth of vegetarian and vegan children (2023)
- HH-12148Effects of zinc carnosine on bone loss in mice with diabetic osteoporosis. (2026)
- HH-12265Hypophosphatemia: A Practical Guide to Evaluation and Management. (2022)
- HH-12365Vitamin D and Fracture Healing. (2026)
- HH-135980No evidence that the skeletal non-response to potassium alkali supplements in healthy postmenopausal women depends on blood pressure or sodium chloride intake (2012)
- HH-180333Effect of Low-Dose Vitamin K2 Supplementation on Bone Mineral Density in Middle-Aged and Elderly Chinese: A Randomized Controlled Study (2020)
- HH-18455Role of calcium and vitamin D in the prevention and the treatment of postmenopausal osteoporosis: an overview. (1995)
- HH-18549Long-term effects of calcium supplementation on bone loss and fractures in postmenopausal women: a randomized controlled trial. (1995)
- HH-18578Magnesium supplementation and osteoporosis. (1995)
- HH-18584Trabecular bone density in a two year controlled trial of peroral magnesium in osteoporosis. (1993)
- HH-18591Calcium supplementation increases bone density in adolescent girls. (1994)
- HH-19236Role of nutritional zinc in the prevention of osteoporosis (2010)
- HH-19237Zinc supplementation improves bone density in patients with thalassemia: a double-blind, randomized, placebo-controlled trial (2013)
- HH-22441Ionized hypercalcemia in cats with azotemic chronic kidney disease (2012-2018) (2022)
- HH-26706Effects of Mineral Composition of Drinking Water on Risk for Stone Formation and Bone Metabolism in Idiopathic Calcium Nephrolithiasis (1996)
- HH-26790[Mineral waters and bone health] (2004)
- HH-2799Regulation of Phosphate Homeostasis by PTH, Vitamin D, and FGF23 (2010)
- HH-291868A COMPARATIVE STUDY OF EFFICACY OF CALCIUM + VITAMIN D3 AND CALCIUM + VITAMIN D3 + VITAMIN K2 IN PREVENTION OF OSTEOPOROSIS IN POSTMENOPAUSAL OSTEOPENIC WOMEN WHO ARE ADOPTING A SEDENTARY PATTERN OF LIFE STYLE (2013)
- HH-292065Investigating the Influence of Vitamin D Replacement Therapy on Magnesium Status (2018)
- HH-3049Effects of Sodium Bicarbonate in CKD Stages 3 and 4: A Randomized, Placebo-Controlled, Multicenter Clinical Trial (2020)
- HH-376007Calcium and vitamin D in the management of osteoporosis (2021)
- HH-3795Lithium and lithium carbonate prescribing information (2018)
- HH-45806Interactions among iron, calcium, phosphorus and magnesium in the nutritionally iron-deficient rat (1998)
- HH-45838Effect of hypermagnesemia on the adenohypophyseal-gonadal function, parathyroid hormone secretion and some other hormonal indicators (1993)
- HH-460620Magnesium modulates parathyroid hormone secretion and upregulates parathyroid receptor expression at moderately low calcium concentration (2013)
- HH-46596Vitamin D Status, Cardiovascular Risk Profile, and miRNA-21 Levels in Hypertensive Patients: Results of the HYPODD Study (2022)
- HH-46636Effect of vitamin D on the intestinal absorption of 203Pb and 47Ca in chicks (1982)
- HH-501187The effect of high-dose vitamin D supplementation on calciotropic hormones and bone mineral density in obese subjects with low levels of circulating 25-hydroxyvitamin d: results from a randomized controlled study (2013)
- HH-5414The effect of calcium supplementation in people under 35 years old: A systematic review and meta-analysis of randomized controlled trials (2022)
- HH-5903Prevention of bone loss by vitamin D supplementation in elderly women: a randomized double-blind trial (1995)
- HH-89819Bone abnormalities in young male rats with iron intervention and possible mechanisms (2018)
Studies that name it
1,852 approved studies in the library name PTH (Parathyroid Hormone). 231 of them are recorded as a trial, an observational study or a pooled analysis; most rows record no design.
The 8 below are listed in this order: studies that name it in the title, then recorded trials, observational studies and pooled analyses, then the newest.
- Discovery and characterization of canvuparatide, a once-weekly parathyroid hormone analog for the treatment of hypoparathyroidism (2026) · HH-191106 · trial, observational study or pooled analysis
- Effect of Exercise on Parathyroid Hormone Levels in Dialysis Patients: A Systematic Review and Meta-Analysis (2026) · HH-217335 · trial, observational study or pooled analysis
- Efficacy and safety of parathyroid hormone analogs therapy on hypoparathyroidism: a meta-analysis (2026) · HH-460507 · trial, observational study or pooled analysis
- Parathyroid hormone-related protein-mediated hypercalcemia of malignancy: insights from a multicenter clinical data warehouse (2026) · HH-603979 · trial, observational study or pooled analysis
- Prognosis comparison in chronic kidney disease stages 4-5 patients with low parathyroid hormone level due to different causes (2026) · HH-615049 · trial, observational study or pooled analysis
- Parathyroid hormone guided protocols for hypocalcemia management after thyroidectomy: A systematic review (2026) · HH-815328 · trial, observational study or pooled analysis
- Breast milk intake, intact parathyroid hormone, and %tubular phosphate reabsorption as predictors of bone mineral density at term-equivalent age in very preterm and/or low-birth-weight infants: A prospective cohort study (2026) · HH-834250 · trial, observational study or pooled analysis
- Serum 25-Hydroxyvitamin D and Intact Parathyroid Hormone as Functional Biomarkers of Bone Mass in Early Childhood (2025) · HH-239282 · trial, observational study or pooled analysis
Counted on 2026-11-22 across 923,626 approved studies: a study is counted when its title or its one-line takeaway names the marker. A count is where the library has been pointed, never a verdict on the field. Open PTH (Parathyroid Hormone) in the Library
Foods that move it
The food matrix ties a food to a marker in two ways, and they are kept apart. A food leading with a nutrient is a measurement of the food, not a promise about a result.
Through the nutrients they lead with
For the nutrients above that the library ties to this marker by a named relation, these are the foods the matrix lists as leading with each one (the most per 100 g first, from USDA), and the ingredient brief where one exists.
Calcium
5 of 18 foods shown. Read the Calcium brief
Magnesium
5 of 23 foods shown. Read the Magnesium brief
Vitamin D
Vitamin K
5 of 6 foods shown. Read the Vitamin K brief
Concerns that name it
A concern is a question, not a diagnosis. These concern pages either list this marker among the numbers the Library ties to them, or send you to a panel that reads it.
Enter your numbers
Type in the value from a report you already have, or import the report, and each one is read against the evidence. Your lab values stay on your device. They are never uploaded to The Lab Atlas.
All markers · Questions people ask · Questions: info@thelabatlas.org